{"id":"W4406268174","doi":"10.1016/j.esmoop.2024.104107","title":"Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre","funders":"Ono Pharmaceutical; National Cancer Institute; Celgene; Agilent Technologies; Bristol-Myers Squibb","keywords":"Gastroesophageal Junction; Medicine; Cancer; Internal medicine; Nivolumab; Gastroenterology; Oncology; Adenocarcinoma; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001881049,0.001311802,0.00193066,0.0002652111,0.000294071,0.0007307345,0.0008042399,0.0008465049,0.002269518],"category_scores_gemma":[0.0006349452,0.0004676685,0.00155474,0.0003241502,0.0005762379,0.000508066,0.0003909492,0.001377961,0.000475145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008866937,"about_ca_system_score_gemma":0.001415281,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001236009,"about_ca_topic_score_gemma":0.002641205,"domain_scores_codex":[0.9996341,0.0001797103,0.00001850195,0.00006867907,0.00003312821,0.00006583935],"domain_scores_gemma":[0.9995529,0.00004757808,0.0001008634,0.00005329016,0.00003173095,0.0002137039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8481033,0.03438851,0.02297672,0.0008238741,0.003325684,0.0001068513,0.0001500705,0.001905426,0.01290582,0.0001643087,0.003577765,0.07157183],"study_design_scores_gemma":[0.7833862,0.180662,0.02948187,0.00004309464,0.001290475,0.0001832854,0.00003856345,0.000781878,0.001043824,0.0001197042,0.002945557,0.0000235671],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914382,0.003782918,0.0002706002,0.0002776216,0.00009896006,0.001912809,0.001005609,0.00004498328,0.001168422],"genre_scores_gemma":[0.9878781,0.002562629,0.001441095,0.001125365,0.0002190169,0.002528893,0.002807477,0.00002347474,0.001413905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002269518,"threshold_uncertainty_score":0.009948075,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009857846797699509,"score_gpt":0.3101867163670241,"score_spread":0.3003288695693245,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}